A 52-year-old man with stable COPD presents with persistent dyspnea despite using a short-acting beta-2 agonist (SABA) as needed. He has no features of acute exacerbation. Which drug is the first-line choice for maintenance therapy in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.